FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14170411000001103: Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1888501000001110 Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1888521000001115 Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Bicalutamide 150mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is pack of Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has active ingredient Bicalutamide false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Bicalutamide true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Bicalutamide 150mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start